Leukoencephalopathy with calcifications and cysts (LCC): 5 cases and literature review.
Adolescent
Adult
Aged
Calcinosis
/ complications
Central Nervous System Cysts
/ complications
Cerebral Small Vessel Diseases
/ complications
Child
Child, Preschool
Female
Humans
Infant
Infant, Newborn
Leukoencephalopathies
/ complications
Male
Middle Aged
Mutation, Missense
RNA, Small Nucleolar
/ genetics
Young Adult
Intracranial calcifications and cysts
Leukoencephalopathy
Small vessel disease
Journal
Revue neurologique
ISSN: 0035-3787
Titre abrégé: Rev Neurol (Paris)
Pays: France
ID NLM: 2984779R
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
19
03
2019
revised:
03
06
2019
accepted:
04
06
2019
pubmed:
16
9
2019
medline:
18
12
2020
entrez:
16
9
2019
Statut:
ppublish
Résumé
Leukoencephalopathy with calcifications and cysts (LCC) is a rare autosomal recessive cerebral angiomatous-like microangiopathy characterized by diffuse and asymmetric white-matter lesions associated with multiple calcifications and cysts. The disease is caused by SNORD118 mutations. The entire clinical spectrum of LCC is not yet fully determined. To define the clinical spectrum of LCC, we analyzed data from recently diagnosed cases and from the litterature. Both clinical and imaging features from our five LCC cases harboring compound heterozygous SNORD118 mutations were presented and all cases reported in the litterature reviewed. Ninety-two LCC cases including our five patients were identified. Consanguinity was rare (4%), and 97% of cases were symptomatic. Mean age of first clinical manifestations was 16.1±16.1 years (range 1 month-71 years) and was earlier in men (10.3±14.3 years) than in women (20.2±22.8 years) (P=0.02). The main inaugural symptoms were seizures (36%; mean age at onset: 5.2±9.5 years) and progressive neurological symptoms including ataxia, dystonia and spasticity (26%; 27.8±23.6 years). Intracranial hypertension was less frequently observed (14%), mostly in adults (mean age 31.5±13.2 years). Ischemic or hemorrhagic strokes were inaugural symptoms in two adults (2%). During follow-up, most patients developed progressive extrapyramidal, cerebellar and pyramidal signs (83%), cognitive decline (56%), seizures (37%), intracranial hypertension (30%) or stroke (2%). In LCC, the clinical spectrum is largely heterogeneous and the course of the disease appears highly variable in contrast to other hereditary cerebral small vessel diseases.
Identifiants
pubmed: 31521395
pii: S0035-3787(19)30549-1
doi: 10.1016/j.neurol.2019.06.006
pii:
doi:
Substances chimiques
RNA, Small Nucleolar
0
SNORD118 RNA, human
0
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
170-179Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.